Hey
@joshua.leisk, I have finally made it to the forums! As always, thanks for all of your hard work putting this together. I have been reading this thread since I first found your protocol but I only started posting here as of now. I hope you don't mind a few questions/comments regarding what you said recently. Hopefully I am not missing something due to brain fog.
I think it would be a bit clearer if you refer to 3-HSD as 3a-HSD since you are specifically referring to that isomer - that is the case right? Or are there also suspected issues with 3b-HSD?
More importantly, what makes you think that there are these issues at all (see my question at the end re: sources)?
I also don't quite follow where you are getting the idea that there will be increased allopregnanolone because of a low 3a-HSD level, as it is required for allopregnanolone synthesis:
Many of us have found that supplementing with pregnenolone provides a clear benefit in terms of brain fog, sensory sensitivity, etc., and allopregnanolone (downstream from pregnenolone) has been shown to be a increased with pregnenolone supplementation (eg see
this paper). I personally don't find that this effect can be replicated using DHEA or hydrocortisone, which suggests it is not an adrenally-driven phenomenon.
I also have found your claims regarding low LH and FSH to be a little strange - are you gathering all of these data from current patient cohorts, literature, or are you looking over mechanisms and proposing the issues purely theoretically?
I for one most recently had top of the range FSH and mid range LH, despite having severe ME/CFS etc.